| Schedule of Earnings Per Share, Basic and Diluted |
For periods in which the Company reports net losses, basic and diluted net loss per share are the same because potentially dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | | Six Months Ended June 30, | | | | | 2025 | | 2026 | | | 2025 | | 2026 | | Numerator: | | | | | | | | | | | | | Net income attributable to common stockholders | | | | $ | 5,607 | | | $ | 16,539 | | | | $ | 3,160 | | | $ | 9,893 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Add: Dilutive effect of convertible senior notes, net(1) | | | | — | | | 531 | | | | — | | | — | | | | | | | | | | | | | | | Net income attributable to common stockholders, diluted | | | | $ | 5,607 | | | $ | 17,070 | | | | $ | 3,160 | | | $ | 9,893 | | | Denominator: | | | | | | | | | | | | | Weighted-average common shares outstanding used to calculate net income per share, basic | | | | 95,526,364 | | | 96,573,751 | | | | 94,903,909 | | | 96,736,956 | | | Stock options, RSUs, and ESPP | | | | 7,325,920 | | | 4,783,260 | | | | 8,273,674 | | | 4,677,585 | | Convertible senior notes(2) | | | | — | | | 8,363,835 | | | | — | | | — | | | Weighted-average effect of dilutive securities | | | | 7,325,920 | | | 13,147,095 | | | | 8,273,674 | | | 4,677,585 | | | Weighted-average common shares outstanding used to calculate net income per share, diluted | | | | 102,852,284 | | | 109,720,846 | | | | 103,177,583 | | | 101,414,541 | | | | | | | | | | | | | | | Net income per share, basic | | | | $ | 0.06 | | | $ | 0.17 | | | | $ | 0.03 | | | $ | 0.10 | | | Net income per share, diluted | | | | $ | 0.05 | | | $ | 0.16 | | | | $ | 0.03 | | | $ | 0.10 | | _________(1)For the three months ended June 30, 2026, diluted earnings per share and diluted net income attributable to common stockholders excludes interest expense, net of tax, associated with convertible senior note activity during the year, as evaluated under the if-converted method. (2)For the three months ended June 30, 2026, includes incremental dilutive shares from the 2032 Notes.
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following securities were excluded from the computation of diluted net income per share for the periods presented, due to their anti-dilutive effect:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | | | Six Months Ended June 30, | | | 2025 | | 2026 | | | | 2025 | | 2026 | | | | | | | | | | | | | Options to purchase common stock | | 9,839,891 | | | 2,495,789 | | | | | 9,839,891 | | | 2,068,191 | | | Unvested RSUs | | 3,152,602 | | | 1,214,270 | | | | | 3,152,602 | | | 4,511,636 | | Unvested PRSUs | | — | | | 1,726,737 | | | | | — | | | 1,726,737 | | | Purchase rights committed under the ESPP | | 65,540 | | | 128,889 | | | | | 65,540 | | | 128,889 | | | | | | | | | | | | | | Convertible senior notes | | 15,929,353 | | | 15,114,003 | | | | | 15,929,353 | | | 23,477,838 | | | | | | | | | | | | | | Total | | 28,987,386 | | | 20,679,688 | | | | | 28,987,386 | | | 31,913,291 | |
|